DPYSL2 and urinary bladder carcinoma: In addition, DPYSL2 expression positively correlated with T stage (P = 0.015), N stage (P = 0.011), recurrence and progression (P = 0.012), as well as clinical stage (P < 0.001) (Table 1) in bladder cancer patients.